Arcutis to Present at Upcoming Investor Conferences

Core Insights - Arcutis Biotherapeutics, Inc. is participating in three upcoming investor conferences in September 2025, showcasing its commitment to engaging with investors and stakeholders [1][2] Conference Participation - The company will attend Citi's 2025 Biopharma Back to School Conference on September 2-3, 2025, with a fireside chat scheduled for September 3 at 9:45 am EDT [1] - Arcutis will also participate in Morgan Stanley's 23rd Annual Global Healthcare Conference from September 8-10, 2025, with a fireside chat on September 9 at 2:35 pm EDT [1] - Additionally, the company will be part of HC Wainwright's 27th Annual Global Investment Conference on September 8-10, 2025, with a fireside chat on September 10 at 10:30 am EDT [1] Company Overview - Arcutis is a commercial-stage medical dermatology company focused on innovations for immune-mediated dermatological diseases, with a portfolio of advanced targeted topicals approved for three major inflammatory skin diseases [2] - The company utilizes a unique dermatology development platform and expertise to create differentiated therapies against biologically validated targets, resulting in a robust pipeline for inflammatory dermatological conditions [2]